Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease M<sup>pro</sup>
In the latest few decades, molecular docking has imposed itself as one of the most used approaches for computational drug discovery. Several docking benchmarks have been published, comparing the performance of different algorithms in respect to a molecular target of interest, usually evaluating thei...
Main Authors: | Davide Bassani, Matteo Pavan, Giovanni Bolcato, Mattia Sturlese, Stefano Moro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/2/180 |
Similar Items
-
In Silico Analysis of Peptide-Based Derivatives Containing Bifunctional Warheads Engaging Prime and Non-Prime Subsites to Covalent Binding SARS-CoV-2 Main Protease (M<sup>pro</sup>)
by: Simone Brogi, et al.
Published: (2022-05-01) -
Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CL<sup>Pro</sup> and PL<sup>Pro</sup>) by Molecular Docking and Dynamic Simulation Studies
by: Quaiser Saquib, et al.
Published: (2024-02-01) -
Fluorine Atoms on C<sub>6</sub>H<sub>5</sub>-Corrole Affect the Interaction with M<sup>pro</sup> and PL<sup>pro</sup> Proteases of SARS-CoV-2: Molecular Docking and 2D-QSAR Approaches
by: Otávio Augusto Chaves, et al.
Published: (2022-09-01) -
Synthesis of New <i>bis</i>-furanyl-pyrrolo[3,4-<i>b</i>]pyridin-5-ones via the Ugi-Zhu Reaction and Docking Studies on the Main Protease (M<sup>Pro</sup>) from SARS-CoV-2
by: Ivette Morales-Salazar, et al.
Published: (2021-11-01) -
Potential Inhibitors of SARS-CoV-2 Main Protease (M<sup>pro</sup>) Identified from the Library of FDA-Approved Drugs Using Molecular Docking Studies
by: Dipesh Kumar Verma, et al.
Published: (2022-12-01)